World Vaccine Congress Europe 2026 has ended. This guide stays up as the record of who was there. Next: WVC Europe 2027, Oct 25–27, 2027 in Lyon

Johnson & Johnson at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

Johnson & Johnson takes part in 3 sessions at World Vaccine Congress Europe 2026 in Amsterdam. Its program spans formulation and bioprocess as well as bacterial vaccines. The most concrete reports Phase 3 results from the E.mbrace study, exploring why a 9-valent vaccine (ExPEC9V) did not prevent invasive E. coli disease in older adults.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
Johnson & Johnson
New Brunswick, NJ
Session
Tue Oct 20
14:00
Track Chair
Formulation & Bioprocess
Session
Tue Oct 20
16:00
Track Chair
Formulation & Bioprocess

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Johnson & Johnson

Tell us what you sell and we’ll find the people at Johnson & Johnson most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction